A bill passed unanimously of the Senate Judiciary Committee that seeks to stop big pharma’s anti-competitive behaviors of dodging generic substitution laws and abusing the patent system, to stifle competition.
Senator from Texas John Cornyn co-sponsored the bill. Cornyn said the bill aims to end the anti-competitive gamesmanship by pharmaceutical companies that keeps many prescription medicines unaffordable through product hopping and patent thicketing.
Cornyn also mentions the bill has bi-partisan support and hopes it will be part of a larger bill to lower prescription prices.
(Photo: Shutterstock)
